B of A Securities Downgrades Doximity to Underperform, Lowers Price Target to $20

Benzinga Newsdesk www.benzinga.com Negative 86.6%

Neg 86.6% Neu 0% Pos 0%

B of A Securities analyst Allen Lutz downgrades Doximity (NYSE:DOCS) from Buy to Underperform and lowers the price target from $38 to $20.